参考文献
2020-10-21
1. Istvan, E.S., and Deisenhofer, J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292(5519), 1160-1164 (2001).
2. Tobert, J.A. Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nat. Rev. Drug Discov. 2(7), 517-526 (2003).
3. Asztalos, B.F., Maulf, F.L., Dallal, G.E., et al. Comparison of the effects of high doses of Rosuvastatin versus Atorvastatin on the subpopulations of high-density lipoproteins. Am. J. Cardiol. 99(5), 681-685 (2007).
4. Rubba, P., Marotta, G., and Gentile, M. Efficacy and safety of rosuvastatin in the management of dyslipidemia. Vasc. Health Risk Manag. 5(1), 343-352 (2009).
